📰 Ua News
Page 142 - Ua News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ua. Real-time updates on events, politics, business and more.
January 4, 2022
Big Al from The University of Alabama had a major year. Be sure to check out the 2021 video rewind.
January 4, 2022
Big Al from The University of Alabama had a major year. Be sure to check out the 2021 video rewind.
January 4, 2022
Big Al from The University of Alabama had a major year. Be sure to check out the 2021 video rewind.
January 3, 2022
Big Al from The University of Alabama had a major year. Be sure to check out the 2021 video rewind.
January 3, 2022
The Drug Controller General of India (DCGI) has given its nod to Molnupiravir for Emergency Use Authorisation (EUA) for the treatment of adult patients with Covid-19 and who have high risk of progression of the disease.
January 1, 2022
Novavax Inc will submit a request to the US Food and Drug Administration to authorize its COVID-19 vaccine next month, further delaying the submission it had expected by the end of this year.
December 28, 2021
CDSCO recommended granting permission to manufacture and market anti-Covid pill Molnupiravir for restricted emergency use for treatment of adult patients who have high risk of progression of the disease.
December 28, 2021
Cipla Limited announced on Tuesday that it has been granted Emergency Use Authorization (EUA) permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir, an anti-viral drug to treat mild to moderate Covid-19.
December 27, 2021
HAGÅTÑA (The Guam Daily Post) — Guam awaits further guidance on how the prolonged issue of more than $23.3 million in Pandemic Unemployment Assistance overpayments should be handled, especially if
December 27, 2021
FDA’s recent actions to roll back enforcement policies implemented in response to the COVID-19 pandemic: FDA took another step in that process by publishing guidance documents describing the regulatory requirements for devices that were authorized under the emergency use authorization.